amonafide has been researched along with Necrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, X; Liu, J; Qian, X; Wu, A; Xu, K; Xu, Y | 1 |
| Chen, Z; Lin, B; Liu, J; Qian, X; Xu, Y; Zhang, H | 1 |
2 other study(ies) available for amonafide and Necrosis
| Article | Year |
|---|---|
B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation.
Topics: Adenine; Apoptosis; Benzothiazoles; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cell Shape; Cell Survival; Cytochromes c; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescence; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Intercalating Agents; Mitochondria; Naphthalimides; Necrosis; Organophosphonates; RNA, Messenger; RNA, Small Interfering; Staining and Labeling; Time Factors; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2011 |
7-b, a novel amonafide analogue, cause growth inhibition and apoptosis in Raji cells via a ROS-mediated mitochondrial pathway.
Topics: Adenine; Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Humans; Mitochondria; Models, Biological; Naphthalimides; Necrosis; Organophosphonates; Reactive Oxygen Species; Signal Transduction | 2011 |